TrialInternational journal of hematology2024

A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.

Kensuke Usuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.